论文信息 - A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy‐free approach in HER2‐positive metastatic breast cancer: The HAT study (BOOG 2008‐2003), a Dutch Breast Cancer Research Group trial - 字舞流文

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy‐free approach in HER2‐positive metastatic breast cancer: The HAT study (BOOG 2008‐2003), a Dutch Breast Cancer Research Group trial

S. Sleijfer | A. Jager | S. Linn | H. van Tinteren | F. Erdkamp | A. T. Ten Tije | P. Hamberg | J. Kroep | A. Imholz | J. Portielje | H. de Graaf | Q. V. van Rossum-Schornagel | J. Drooger | J. Heijns | A. Honkoop | A. E. van Leeuwen-Stok | A. Imholz | S. M. de Groot | Jan C. Drooger | Albert J. ten Tije | A. Elise van Leeuwen‐Stok